---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-035093"
form_type: "8-K"
ticker: "BNGO"
cik: "0001411690"
company_name: "Bionano Genomics, Inc."
filed_at: "2023-07-19T23:59:59+00:00"
generated_at: "2026-06-13T06:19:50.045095+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Bionano Genomics updates legal opinion to cover up to 49M shares under ATM facility

## Summary
- Filed updated legal opinion with SEC covering sale of up to 49M shares of common stock under existing ATM facility with Cowen.
- Previous opinion covered 38M shares; increase of 11M shares reflects updated capacity under $200M S-3 registration.
- No changes to the Sales Agreement terms; the opinion reaffirms legality of issuance under Securities Act.
- The increased share limit provides additional flexibility for potential capital raises under the existing at-the-market program.

## SEC filing metadata
- accession: 0001140361-23-035093
- form_type: 8-K
- ticker: BNGO
- cik: 0001411690
- company_name: Bionano Genomics, Inc.
- filed_at: 2023-07-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411690/000114036123035093/0001140361-23-035093-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411690/000114036123035093/brhc20056046_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-035093
- JSON: https://secwatch.observer/filing/0001140361-23-035093.json
- Plain text: https://secwatch.observer/filing/0001140361-23-035093.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.